DDX3Y and neoplasm: Since the survival of Daudi cells depends on DDX3Y overexpression because DDX3X expression is undetectable, these results suggest RK-33 is also effective in blocking DDX3Y to slow down tumor progression and that inhibition of both DDX3 paralogues can contribute to tumor suppression.